+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Analytical Testing Outsourcing Market by Services, Testing Technique, End-use - Global Forecast 2025-2030- Product Image
Pharmaceutical Analytical Testing Outsourcing Market by Services, Testing Technique, End-use - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Analytical Testing Outsourcing Market by Services, Testing Technique, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454989
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Analytical Testing Outsourcing Market grew from USD 9.23 billion in 2023 to USD 10.07 billion in 2024. It is expected to continue growing at a CAGR of 9.38%, reaching USD 17.30 billion by 2030.

The scope and definition of pharmaceutical analytical testing outsourcing entail the delegation of laboratory testing services to third-party service providers, which include safety testing, quality control, method validation, stability testing, and raw material testing. This necessity arises due to stringent regulatory requirements, cost efficiency, and the need for high-tech expertise in testing and diagnostics. Its application is manifold, encompassing drug development, production, and commercialization phases, while the end-use scope includes pharmaceutical companies, biotechnology firms, and medical device manufacturers. Key growth factors in this market include increased R&D investments, accelerated drug approval processes, a rise in complex biologics, increased pharmaceutical production, and regulatory pressure to ensure drug safety and efficacy. Potential opportunities lie in the growing demand for generic drugs, personalized medicine, and development in emerging markets, which offer cost advantages. To capitalize on these opportunities, companies should invest in technological advancements like automated testing and data analytics to improve efficiency and accuracy.

However, the market faces limitations like data privacy concerns, a high level of competition that could squeeze profit margins, and complexities resulting from maintaining quality control during outsourcing. Additionally, the challenge of intellectual property protection and potential communication issues between pharmaceutical companies and service providers also affects growth. Areas ripe for innovation include AI-driven analytics, advanced bioanalytical testing technologies, and integrated solutions for seamless communication. Research into these areas could lead to better cost management and service accuracy. The nature of the market is dynamic and competitive, with an emphasis on technological innovation and strategic partnerships. Companies willing to tackle data security and regulatory compliance issues while leveraging innovative technologies may gain a competitive edge. Recommendations for firms include investing in skilled personnel training, enhancing digital infrastructure, and forming alliances with niche analytical service providers to optimize outsourcing benefits while mitigating risks.

Understanding Market Dynamics in the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing research and development in drug discovery and development
    • Complexity of drug formulations and need for compliance with stringent regulatory standards
    • Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
  • Market Restraints
    • High cost of analytical instruments and maintaining state-of-the-art facilities
  • Market Opportunities
    • Emerging technological advancements in drug testing procedures
    • Increasing investments in the pharmaceutical industry
  • Market Challenges
    • Concerns associated with intellectual property rights

Exploring Porter’s Five Forces for the Pharmaceutical Analytical Testing Outsourcing Market

Porter’s Five Forces framework further strengthens the insights of the Pharmaceutical Analytical Testing Outsourcing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pharmaceutical Analytical Testing Outsourcing Market

External macro-environmental factors deeply influence the performance of the Pharmaceutical Analytical Testing Outsourcing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Ascendia Pharmaceuticals, BioAgilytix, Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific SE, ICON PLC, Intertek Group PLC, Laboratory Corporation of America Holdings, LGM Pharma, Medpace Holdings, Inc., Merck KGaA, Pace Analytical Services, Inc., SGS SA, Societal CDMO, Source BioScience, Syneos Health, Thermo Fisher Scientific Inc., West Pharmaceutical Services, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Services
    • Bioanalytical Testing
      • Clinical
      • Non-Clinical
    • Method Development & Validation
      • Extractable & Leachable
      • Impurity Method
      • Technical Consulting
    • Stability Testing
      • Accelerated Stability Testing
      • Drug Substance
      • Photostability Testing
      • Stability Indicating Method Validation
  • Testing Technique
    • Chromatography
    • Mass Spectrometry
    • Spectroscopy
  • End-use
    • Biopharmaceuticals & Pharmaceuticals
    • Contract Manufacturing Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing research and development in drug discovery and development
5.1.1.2. Complexity of drug formulations and need for compliance with stringent regulatory standards
5.1.1.3. Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
5.1.2. Restraints
5.1.2.1. High cost of analytical instruments and maintaining state-of-the-art facilities
5.1.3. Opportunities
5.1.3.1. Emerging technological advancements in drug testing procedures
5.1.3.2. Increasing investments in the pharmaceutical industry
5.1.4. Challenges
5.1.4.1. Concerns associated with intellectual property rights
5.2. Market Segmentation Analysis
5.2.1. Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products
5.2.2. Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples
5.2.3. End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Pharmaceutical Analytical Testing Outsourcing Market, by Services
6.1. Introduction
6.2. Bioanalytical Testing
6.2.1. Clinical
6.2.2. Non-Clinical
6.3. Method Development & Validation
6.3.1. Extractable & Leachable
6.3.2. Impurity Method
6.3.3. Technical Consulting
6.4. Stability Testing
6.4.1. Accelerated Stability Testing
6.4.2. Drug Substance
6.4.3. Photostability Testing
6.4.4. Stability Indicating Method Validation
7. Pharmaceutical Analytical Testing Outsourcing Market, by Testing Technique
7.1. Introduction
7.2. Chromatography
7.3. Mass Spectrometry
7.4. Spectroscopy
8. Pharmaceutical Analytical Testing Outsourcing Market, by End-use
8.1. Introduction
8.2. Biopharmaceuticals & Pharmaceuticals
8.3. Contract Manufacturing Organizations
9. Americas Pharmaceutical Analytical Testing Outsourcing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Sterling Accuris expands into pharmaceutical and analytical testing through new acquisition
12.3.2. Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 51. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 53. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 54. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 57. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 59. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 82. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 83. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 84. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 85. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 89. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 90. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 91. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 92. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 101. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 102. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 103. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 137. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 138. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 139. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 156. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 158. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 162. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 164. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 166. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 167. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 168. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 170. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 172. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 174. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 176. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 180. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 182. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 190. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 191. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 192. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 194. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 195. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 208. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 210. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 212. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 214. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 216. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 218. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 219. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 220. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 221. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 222. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 223. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 224. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 225. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 246. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 248. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 262. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 263. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

The leading players in the Pharmaceutical Analytical Testing Outsourcing market, which are profiled in this report, include:
  • Ajinomoto Bio-Pharma
  • Alcami Corporation
  • AptarGroup, Inc.
  • Ascendia Pharmaceuticals
  • BioAgilytix
  • Cambrex Corporation
  • Catalent, Inc
  • Charles River Laboratories International, Inc.
  • Element Materials Technology
  • Eurofins Scientific SE
  • ICON PLC
  • Intertek Group PLC
  • Laboratory Corporation of America Holdings
  • LGM Pharma
  • Medpace Holdings, Inc.
  • Merck KGaA
  • Pace Analytical Services, Inc.
  • SGS SA
  • Societal CDMO
  • Source BioScience
  • Syneos Health
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.3 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Pharmaceutical Analytical Testing Outsourcing - Global Strategic Business Report - Product Image

Pharmaceutical Analytical Testing Outsourcing - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market by Type, Service, End User, and Region 2024-2032 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market by Type, Service, End User, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Pharmaceutical Analytical Testing Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 113 Pages
  • Global
From
Pharmaceutical Analytical Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Pharmaceutical Analytical Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 127 Pages
  • Global
From
2024 Global Forecast for Pharmaceutical Analytical Testing Outsourcing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Pharmaceutical Analytical Testing Outsourcing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Market

The Pharmaceutical Analytical Testing Outsourcing market is a subset of the Drug Discovery industry, which involves the development of new drugs and treatments. It is a highly specialized field that requires a range of analytical testing services to ensure the safety and efficacy of new drugs. Outsourcing these services to specialized companies can help reduce costs and speed up the drug development process. Analytical testing services include a range of activities such as method development and validation, stability testing, impurity profiling, and bioanalytical testing. These services are essential for ensuring the quality and safety of new drugs, and for meeting regulatory requirements. Companies in the Pharmaceutical Analytical Testing Outsourcing market include Eurofins Scientific, SGS, Intertek, Charles River Laboratories, and WuXi AppTec. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.